Search results
Results From The WOW.Com Content Network
Anti-Saccharomyces cerevisiae antibodies (ASCAs) are antibodies against antigens presented by the cell wall of the yeast Saccharomyces cerevisiae. These antibodies are directed against oligomannose sequences α-1,3 Man (α-1,2 Man α-1,2 Man) n (n = 1 or 2). [1] ASCAs and perinuclear antineutrophil cytoplasmic antibodies (pANCAs) are the two ...
Pages in category "Antibodies" The following 71 pages are in this category, out of 71 total. ... Anti–Saccharomyces cerevisiae antibody; Secretory component;
Antibodies against S. cerevisiae are found in 60–70% of patients with Crohn's disease and 10–15% of patients with ulcerative colitis, and may be useful as part of a panel of serological markers in differentiating between inflammatory bowel diseases (e.g. between ulcerative colitis and Crohn's disease), their localization and severity.
p-ANCA is associated with several medical conditions: [3] It is fairly specific, but not sensitive for ulcerative colitis, so is not useful as a sole diagnostic test. [4] When measured together with anti-saccharomyces cerevisiae antibodies (ASCA), p-ANCA has been estimated to have a specificity of 97% and a sensitivity of 48% in differentiating patients with ulcerative colitis from normal ...
An antibody digested by papain yields three fragments, two Fab fragments and one Fc fragment An antibody digested by pepsin yields two fragments: a F(ab') 2 fragment and a pFc' fragment The fragment crystallizable region ( Fc region ) is the tail region of an antibody that interacts with cell surface receptors called Fc receptors and some ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Notably, deficiency of hexosaminidases results in clinically significant Tay-Sachs and Sandhoff diseases, which also implicates Hex and paucimannosidic proteins in those conditions. Endogenous and exogenous binding partners of mammalian paucimannosidic glycans have been suggested, [ 3 ] including the macrophage mannose receptor (CD206) and ...